China's BeiGene signals ramp-up with Sigma-Aldrich deal; Singapore's Biosensors completes PhII stent trial enrollment;

> BeiGene, Sigma-Aldrich manufacturing equipment deal signals ramp-up. Release

> Singapore's Biosensors completed enrollment for its CREDIT II stent trial. Release

> Taiwan is in a pact to help Latin America on Ebola equipment. Release

> Taiwan's PharmaEssentia completed Phase III recruitment for Ropeginterferon alfa-2b. Release

> Australia's Benitec Biopharma dosed a fourth patient in hep C trial. Release

> China FDA accepted Eisai's Aricept additional indication application. Release